Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir

Raltegravir induced a transient increment on total HTLV-2 DNA proviral load in HTLV-2/HIV-1-coinfected individuals on suppressive cART after 24 weeks.